60 participants
Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-09-29
- Start Date:
- 2017-10-31
- Completion:
- 2018-10-31
Conditions
- Ovarian Cancer
Interventions
- DRUG
No Results Yet